Asaflow


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 21.7%
Mantle Cell Lymphoma 19.6%
Drug Use For Unknown Indication 13.0%
Hypertension 9.8%
Depression 7.6%
Cardiovascular Event Prophylaxis 4.3%
Atrial Fibrillation 3.3%
Acute Coronary Syndrome 2.2%
Asthma 2.2%
Cerebrovascular Accident Prophylaxis 2.2%
Hypercholesterolaemia 2.2%
Prophylaxis 2.2%
Sleep Disorder 2.2%
Antidepressant Therapy 1.1%
Arthralgia 1.1%
Arthropathy 1.1%
Chronic Myeloid Leukaemia 1.1%
Complex Partial Seizures 1.1%
Coronary Artery Disease 1.1%
Dementia 1.1%
Ischaemic Stroke 13.6%
Rhabdomyolysis 9.1%
Thrombocytopenia 9.1%
Upper Gastrointestinal Haemorrhage 9.1%
Gastrointestinal Haemorrhage 4.5%
Haemorrhage Intracranial 4.5%
Oesophagitis 4.5%
Pancreatitis 4.5%
Pleural Effusion 4.5%
Rectal Haemorrhage 4.5%
Resuscitation 4.5%
Skin Discolouration 4.5%
Suicide Attempt 4.5%
Tachycardia 4.5%
Urticaria 4.5%
Vomiting 4.5%
Weight Decreased 4.5%
Concomitant
Product Used For Unknown Indication 24.6%
Drug Use For Unknown Indication 15.9%
Hypertension 14.7%
Rheumatoid Arthritis 5.2%
Prophylaxis 4.8%
Diabetes Mellitus 4.1%
Hypercholesterolaemia 3.7%
Non-small Cell Lung Cancer 3.7%
Multiple Myeloma 3.5%
Pain 2.3%
Osteoporosis 2.2%
Asthma 2.1%
Insomnia 1.8%
Prophylaxis Against Renal Transplant Rejection 1.7%
Atrial Fibrillation 1.7%
Thrombosis Prophylaxis 1.7%
Arthritis 1.6%
Depression 1.6%
Plasma Cell Myeloma 1.6%
Breast Cancer 1.4%
Vomiting 11.2%
Thrombocytopenia 9.3%
Myocardial Infarction 6.2%
Pneumonia 6.2%
Pyrexia 5.6%
Renal Failure 5.6%
Crohn's Disease 5.0%
Renal Failure Acute 5.0%
Dyspnoea 4.3%
Pulmonary Embolism 4.3%
Weight Decreased 4.3%
Weight Increased 4.3%
Acute Pulmonary Oedema 3.7%
Faecaloma 3.7%
Sepsis 3.7%
Transient Ischaemic Attack 3.7%
Ventricular Fibrillation 3.7%
Visual Impairment 3.7%
Cardiac Disorder 3.1%
Cerebrovascular Accident 3.1%

Drug Data